HDT Bio

About:

HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.

Website: https://www.hdt.bio

Twitter/X: hdtbio

Top Investors: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Zoic Capital, US Army, Medical CBRN Defense Consortium

Description:

HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology. The company's technology platforms and products cover a wide range of immunotherapy modalities and mechanisms of action, including innate immunity activation, adaptive immune response amplification, and tumor-tight junction disruption. Its mission is to maintain the rapid and significant progress made in the fight against the world's deadliest infectious diseases by developing cutting-edge immunotherapy technologies in a cost-effective manner across leading markets as well as low or middle-income countries.